-
Je něco špatně v tomto záznamu ?
Evaluation of the insertion parameters and complications of the i-gel Plus airway device for maintaining patent airway during planned procedures under general anaesthesia: a protocol for a prospective multicentre cohort study
O. Klementova, TK. Bhoday, J. Werner, AM. Lopez, W. Donaldson, E. Lichnovsky, T. Gaszyński, T. Henlin, J. Bruthans, J. Ulrichova, M. Lukes, J. Blaha, M. Kral, L. Gomez, R. Berge, J. Holland, F. McAleavey, S. Arava, L. Merjava Skripecka, S....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Nursing & Allied Health Database (ProQuest)
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
Family Health Database (ProQuest)
od 2011-01-01
Psychology Database (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- celková anestezie * škodlivé účinky MeSH
- dospělí MeSH
- intratracheální intubace metody MeSH
- kohortové studie MeSH
- laryngální masky * škodlivé účinky MeSH
- lidé MeSH
- multicentrické studie jako téma MeSH
- prospektivní studie MeSH
- zajištění dýchacích cest metody MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
INTRODUCTION: Supraglottic airway devices represent a less invasive method of airway management than tracheal intubation during general anaesthesia. Their continued development is focused mainly on improvements in the insertion success rate and minimalisation of perioperative and postoperative complications. The i-gel Plus is a novel, anatomically preshaped supraglottic airway device which achieves a perilaryngeal seal due to a non-inflatable cuff made of a soft thermoplastic elastomer. The purpose of this cohort study is to assess the success rate of the i-gel Plus use during elective procedures under general anaesthesia, its intraoperative performance, and the degree of postoperative complications. METHODS AND ANALYSIS: This is a multicentre, prospective, interventional cohort study. The enrolment will take place in seven centres in four European countries. We plan to enrol 2000 adult patients in total, who are scheduled for elective surgery under general anaesthesia, and with an indication for use of a supraglottic airway device for management of their airway. The study is projected to run over a period of 18 months. The primary outcome of the study is the total success rate of the i-gel Plus insertion in terms of successful ventilation and oxygenation through the device. Secondary outcomes include perioperative parameters, such as insertion time, seal/leak pressures, number of insertion attempts and postoperative adverse events and complications. Postoperative follow-up will be performed at 1 hour, 24 hours in all patients, and for selected patients at 3 and 6 months. ETHICS AND DISSEMINATION: The cohort study has received the following ethical approvals: General University Hospital Prague, University Hospital Olomouc, University Military Hospital Prague, University Hospital Barcelona, University Hospital Lodz, Antrim Area Hospital, Craigavon Area Hospital, Office for Research Ethics Committees Northern Ireland. The results will be published in peer-reviewed journals and presented at relevant anaesthesia conferences. TRIAL REGISTRATION NUMBER: ISRCTN86233693;Pre-results.
Anaesthesia and Intensive Medicine General University Hospital Prague Praha Czech Republic
Department of Anaesthesia Antrim Area Hospital Antrim UK
Department of Anaesthesia Craigavon Area Hospital Portadown UK
Department of Anaesthesiology and Intensive Therapy Medical University of Lodz Lodz Poland
Department of Anesthesia Hospital Clinic de Barcelona Barcelona Spain
Department of Anesthesiology and Intensive Therapy Medical University of Lodz Lodz Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011670
- 003
- CZ-PrNML
- 005
- 20220506131236.0
- 007
- ta
- 008
- 220425s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/bmjopen-2021-053215 $2 doi
- 035 __
- $a (PubMed)34930740
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Klementova, Olga $u Department of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc, Olomouc, Czech Republic
- 245 10
- $a Evaluation of the insertion parameters and complications of the i-gel Plus airway device for maintaining patent airway during planned procedures under general anaesthesia: a protocol for a prospective multicentre cohort study / $c O. Klementova, TK. Bhoday, J. Werner, AM. Lopez, W. Donaldson, E. Lichnovsky, T. Gaszyński, T. Henlin, J. Bruthans, J. Ulrichova, M. Lukes, J. Blaha, M. Kral, L. Gomez, R. Berge, J. Holland, F. McAleavey, S. Arava, L. Merjava Skripecka, S. Sobczyk, T. Tyll, P. Michalek
- 520 9_
- $a INTRODUCTION: Supraglottic airway devices represent a less invasive method of airway management than tracheal intubation during general anaesthesia. Their continued development is focused mainly on improvements in the insertion success rate and minimalisation of perioperative and postoperative complications. The i-gel Plus is a novel, anatomically preshaped supraglottic airway device which achieves a perilaryngeal seal due to a non-inflatable cuff made of a soft thermoplastic elastomer. The purpose of this cohort study is to assess the success rate of the i-gel Plus use during elective procedures under general anaesthesia, its intraoperative performance, and the degree of postoperative complications. METHODS AND ANALYSIS: This is a multicentre, prospective, interventional cohort study. The enrolment will take place in seven centres in four European countries. We plan to enrol 2000 adult patients in total, who are scheduled for elective surgery under general anaesthesia, and with an indication for use of a supraglottic airway device for management of their airway. The study is projected to run over a period of 18 months. The primary outcome of the study is the total success rate of the i-gel Plus insertion in terms of successful ventilation and oxygenation through the device. Secondary outcomes include perioperative parameters, such as insertion time, seal/leak pressures, number of insertion attempts and postoperative adverse events and complications. Postoperative follow-up will be performed at 1 hour, 24 hours in all patients, and for selected patients at 3 and 6 months. ETHICS AND DISSEMINATION: The cohort study has received the following ethical approvals: General University Hospital Prague, University Hospital Olomouc, University Military Hospital Prague, University Hospital Barcelona, University Hospital Lodz, Antrim Area Hospital, Craigavon Area Hospital, Office for Research Ethics Committees Northern Ireland. The results will be published in peer-reviewed journals and presented at relevant anaesthesia conferences. TRIAL REGISTRATION NUMBER: ISRCTN86233693;Pre-results.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a zajištění dýchacích cest $x metody $7 D058109
- 650 12
- $a celková anestezie $x škodlivé účinky $7 D000768
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intratracheální intubace $x metody $7 D007442
- 650 12
- $a laryngální masky $x škodlivé účinky $7 D017214
- 650 _2
- $a multicentrické studie jako téma $7 D015337
- 650 _2
- $a prospektivní studie $7 D011446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bhoday, Taranpreet Kaur $u Department of Anesthesiology and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Werner, Jakub $u Department of Anesthesiology and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Lopez, Ana M $u Department of Anesthesia, Hospital Clinic de Barcelona, Barcelona, Spain
- 700 1_
- $a Donaldson, Will $u Department of Anaesthesia, Antrim Area Hospital, Antrim, UK
- 700 1_
- $a Lichnovsky, Erik $u Department of Anaesthesia, Craigavon Area Hospital, Portadown, UK
- 700 1_
- $a Gaszyński, Tomasz $u Department of Anaesthesiology and Intensive Therapy, Medical University of Lodz, Lodz, Poland
- 700 1_
- $a Henlin, Tomas $u Department of Anesthesia and Intensive Medicine, Military University Hospital Prague, Praha, Czech Republic
- 700 1_
- $a Bruthans, Jan $u Department of Anesthesiology and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Ulrichova, Jitka $u Department of Anesthesiology and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Lukes, Martin $u Department of Anesthesiology and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Blaha, Jan $u Department of Anesthesiology and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic
- 700 1_
- $a Kral, Michal $u Department of Anesthesiology and Intensive Medicine, University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Gomez, Lidia $u Department of Anesthesia, Hospital Clinic de Barcelona, Barcelona, Spain
- 700 1_
- $a Berge, Raquel $u Department of Anesthesia, Hospital Clinic de Barcelona, Barcelona, Spain
- 700 1_
- $a Holland, Jonathan $u Department of Anaesthesia, Antrim Area Hospital, Antrim, UK
- 700 1_
- $a McAleavey, Francis $u Department of Anaesthesia, Antrim Area Hospital, Antrim, UK
- 700 1_
- $a Arava, Shiva $u Department of Anaesthesia, Craigavon Area Hospital, Portadown, UK
- 700 1_
- $a Merjava Skripecka, Lubica $u Department of Anaesthesia, Craigavon Area Hospital, Portadown, UK
- 700 1_
- $a Sobczyk, Sebastian $u Department of Anesthesiology and Intensive Therapy, Medical University of Lodz, Lodz, Poland
- 700 1_
- $a Tyll, Tomas $u Department of Anesthesia and Intensive Medicine, Military University Hospital Prague, Praha, Czech Republic
- 700 1_
- $a Michalek, Pavel $u Anaesthesia and Intensive Medicine, General University Hospital in Prague, Praha, Czech Republic pavel.michalek@vfn.cz $1 https://orcid.org/0000000181195927 $7 xx0079908
- 773 0_
- $w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 11, č. 12 (2021), s. e053215
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34930740 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131228 $b ABA008
- 999 __
- $a ok $b bmc $g 1789329 $s 1162868
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 12 $d e053215 $e 20211220 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
- LZP __
- $a Pubmed-20220425